Pulmonx Corporation provided revenue guidance for the third quarter ended September 30, 2023. The company's total worldwide revenue for the third quarter of 2023 is anticipated to be approximately $17.6 million, representing growth of approximately 30% over the same quarter last year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.06 USD | +1.29% | -6.24% | -44.63% |
04/06 | Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target | MT |
01/05 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.63% | 274M | |
+75.69% | 12.57B | |
+6.32% | 6.62B | |
+14.03% | 5.45B | |
-16.76% | 4.88B | |
+20.13% | 4.29B | |
-20.15% | 4.06B | |
-22.44% | 2.93B | |
+54.92% | 2.49B | |
+1.98% | 2.06B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Third Quarter Ended September 30, 2023